Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study by Banning, AP, Serruys, P, De Maria, GL, Ryan, N, Walsh, S, Gonzalo, N, Jan van Geuns, R, Onuma, Y, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, SP, Piek, JJ, Appleby, C, Fath-Ordoubadi, F, Zaman, A, Van Mieghem, NM, Uren, N, Zueco, J, Buszman, P, Iniguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, de Vries, T, Taggart, D, Farooq, V, Spitzer, E, Tijssen, J, Escaned, J

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. by Escaned, J, Collet, C, Ryan, N, De Maria, G, Walsh, S, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, S, Ej West, N, Piek, J, Zaman, A, Fath-Ordoubadi, F, Stables, R, Appleby, C, van Mieghem, N, van Geuns, R, Uren, N, Zueco, J, Buszman, P, Iñiguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, Hanratty, C, Cavalcante, R, Kappetein, A, Taggart, D, van Es, G, Morel, M, de Vries, T, Onuma, Y, Farooq, V, Serruys, P, Banning, A